Synergy between Natriuretic Peptides and Phosphodiesterase 5 Inhibitors Ameliorates Pulmonary Arterial Hypertension

類似資料

• Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
  著者:: Bubb, Kristen J, 等
  出版事項: (2014)
• Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide–cyclic GMP signalling
  著者:: Madhani, Melanie, 等
  出版事項: (2003)
• Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
  著者:: Baliga, Reshma S, 等
  出版事項: (2009)
• Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
  著者:: Baliga, Reshma S, 等
  出版事項: (2011)
• New perspectives for the treatment of pulmonary hypertension
  著者:: Baliga, Reshma S, 等
  出版事項: (2011)